Prevalence of atrial fibrillation and eligibility for anticoagulants in the community (Q50861959)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 1998

edit

Language	Label	Description	Also known as
English	Prevalence of atrial fibrillation and eligibility for anticoagulants in the community	scientific article published in October 1998

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

title

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

main subject

atrial fibrillation

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

anticoagulant

1 reference

based on heuristic

inferred from title

author name string

M Sudlow

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

R Thomson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

B Thwaites

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

H Rodgers

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

R A Kenny

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

language of work or name

English

0 references

publication date

1 October 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

published in

The Lancet

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

volume

352

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

issue

9135

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

page(s)

1167-1171

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

cites work

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation and mortality in an elderly population

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for atrial fibrillation in primary care

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

An evidence based approach to individualising treatment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin for atrial fibrillation. The patient's perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations on blood pressure measurement

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a Population Screening Questionnaire to Assess Prevalence of Stroke

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Service provision and use of anticoagulants in atrial fibrillation.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: The stroke prevention in atrial fibrillation study.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901401-9

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0140-6736(98)01401-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

PubMed publication ID

9777832

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9777832

retrieved

24 March 2018

reference URL

http://europepmc.org/abstract/MED/9777832

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50861959&oldid=2262149133"